Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.

Journal of surgical oncology - 1 Feb 2002

Shpitz B, Bomstein Y, Sternberg A, Klein E, Tiomkin V, Kaufman A, Groisman G, Bernheim J

Abstract excerpt

BACKGROUND AND OBJECTIVES: Phyllodes tumor (PT) is a biphasic tumor with unpredictable behavior. Our study aimed to evaluate clinicopathologic factors and biomarkers that may be helpful in predicting the outcome of these tumors. METHODS: We evaluated immunoreactivity of p53, c-erbB-2, and Ki-67 in 23 PT treated over a 10-year period. The proliferative activity in PT and expression of p53 and c-erbB-2 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Ki-67 Antigen

Share to Mastectomy

Share to Receptor, ErbB-2

Share to Survival Analysis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 11815995
DOI: 10.1002/jso.10049

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.PMID 11815995Read ↗

Phyllodes Tumors: Diagnostic, Investigative and Therapeutic Challenges with Special Focus on Malignant Phyllodes TumorsSemantic proximity Read ↗

Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade.Semantic proximity Read ↗

Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.Semantic proximity Read ↗

Immunohistochemical and Molecular Markers in Breast Phyllodes TumorsSemantic proximity Read ↗

Recent insights into the molecular pathogenesis of mammary phyllodes tumours.Semantic proximity Read ↗

Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.Semantic proximity Read ↗

p53 protein expression and gene mutation in phyllodes tumors of the breast.Semantic proximity Read ↗

Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.Semantic proximity Read ↗

Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components.Semantic proximity Read ↗

Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast.Semantic proximity Read ↗

TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast.Semantic proximity Read ↗

Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.